Eight hub genes as potential biomarkers for breast cancer diagnosis and prognosis: A TCGA-based study

doi:10.5306/wjco.v13.i8.675

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4967)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

216

WORD

HTML

2310

Figures (1-6)

359

Tables (1-1)

232

Sum=3187

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

205

Download

505

Sum=710

Publishing Process of This Article

Item

Count

Browse

355

Download

715

Sum=1070

Aug 24, 2022 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Clin Oncol. Aug 24, 2022; 13(8): 675-687
Published online Aug 24, 2022. doi: 10.5306/wjco.v13.i8.675

Full Size Figure Download Figure

Figure 4 Subtype survival analysis of these 10 hub genes in breast cancer patients among The Cancer Genome Atlas cohort. The results are presented by a heatmap and the detailed value on each cell represent the hazard ratio of survival plot.

Citation: Liu N, Zhang GD, Bai P, Su L, Tian H, He M. Eight hub genes as potential biomarkers for breast cancer diagnosis and prognosis: A TCGA-based study. World J Clin Oncol 2022; 13(8): 675-687
URL: https://www.wjgnet.com/2218-4333/full/v13/i8/675.htm
DOI: https://dx.doi.org/10.5306/wjco.v13.i8.675